Press Releases

All Releases
Apr 02, 2019
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
Fiscal 2019 Third Quarter Highlights Net sales of $86.3 million , an increase of 3.0% year over year Gross margin declined 10 basis points year over year to 54.1% GAAP EPS of $0.02 per share; adjusted EPS of $0.19 per share Cash provided by operations of $8.3 million ; capital expenditures of $0.9
Apr 01, 2019
AngioDynamics to Present at the Needham Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 1, 2019-- AngioDynamics, Inc.  (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner , Executive Vice President and Chief
Mar 08, 2019
AngioDynamics Wins Patent Infringement Dispute With Bard
LATHAM, N.Y. --(BUSINESS WIRE)--Mar. 8, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that the United States District Court for the District of Delaware ,
Feb 26, 2019
AngioDynamics to Present at the Barclays Global Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Feb. 26, 2019-- AngioDynamics, Inc.  (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and
Jan 04, 2019
AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results
Fiscal 2019 Second Quarter Highlights Net sales of $91.5 million , an increase of 5.5% year over year Gross margin expanded 440 basis points year over year to 53.7% GAAP EPS of $0.06 per share; adjusted EPS of $0.22 per share Cash provided by operations of $13.0 million ; capital expenditures of
Dec 20, 2018
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 20, 2018-- AngioDynamics, Inc.  (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and
Sep 27, 2018
AngioDynamics Reports Fiscal 2019 First Quarter Financial Results
Fiscal 2019 First Quarter Highlights Net sales of $85.3 million , flat versus prior year Gross margin expanded 380 basis points year over year to 52.1% GAAP EPS of $(0.01) per share; adjusted EPS of $0.16 per share Cash used in operations of $8.9 million ; capital expenditures of $0.7 million
Sep 19, 2018
AngioDynamics to Present at the Cantor Global Healthcare Conference

LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 19, 2018-- AngioDynamics, Inc.  (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner , Executive Vice President and Chief

Aug 23, 2018
AngioDynamics to Present at Two Investor Conferences in September

LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 23, 2018-- AngioDynamics , Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in

Displaying 21 - 40 of 658